newsfilter
← Latest News
Business Wire·

Catabasis Pharmaceuticals Reports Third Quarter 2019 Financial Results and Reviews Business Progress

BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today reported financial results for the third quarter ended September 30, 2019 and reviewed recent business progress.